Arrowhead Research Corporation Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (43)

Latest Posts

About This Stock More About This Stock
Healthcare And Biotechs Feel The Heat As The Market At New Highs
Article By: Tarun Chandra, CFA
Wednesday, May 1, 2019 12:14 PM EDT
The stock market has continued to edge higher and the two major indexes, the Nasdaq (QQQ) and S&P 500 (SPY​), touched the all-time high milestone last week.
In this article: ACAD, ALXN, ARRY, AMRN, ARWR, AXSM, ASND
Read
Looking Ahead Of Wall Street: Arrowhead Research Corp, Oracle Corporation, And BlackBerry Ltd.
Article By: TipRanks
Monday, December 14, 2015 2:43 AM EDT
Holiday shopping and festivities are in full swing, but several companies are slated to report earnings this week ahead of the holidays.
In this article: ORCL, ARWR, BBRY (NOW BB)
Read
E Arrowhead Reports Positive Phase 2a Trial Results For Patients With Hepatitis B
Article By: Terry Chrisomalis
Thursday, September 24, 2015 6:37 PM EDT
Shares of Arrowhead surged 21% after announcing positive phase 2a trial results for its Hepatitis B drug ARC-520.
In this article: ARWR
Read
E Arrowhead Cleared By FDA For Phase 2b Hepatitis B Study
Article By: Terry Chrisomalis
Monday, April 13, 2015 10:30 PM EDT
The drug known as ARC-520 has been cleared by the FDA to proceed with multi-dose trial in hepatitis B patients but shares only briefly rallied before returning flat.
In this article: ARWR
Read
Arrowhead Announces IND Filing To Begin Two Trials For Hepatitis B
Article By: Terry Chrisomalis
Tuesday, December 16, 2014 2:48 PM EDT
(ARWR) jumped 10% today, after the news that the company has filed an IND to the FDA to begin testing two phase 2b trials using its drug ARC-520 in patients with the Hepatitis B virus.
In this article: GILD, ARWR
Read

PARTNER HEADLINES

Latest Tweets for $ARWR

No tweets yet!